The group's principal activity is to conduct research and develop drugs in combination with light devices to treat or detect a variety of conditions in processes known as photodynamic therapy or photodetection. The group develops Levulan(R), which is used to treatment actinic keratoses of the face or scalp. Several additional dermatological and internal indications are under development. Apart from this, the group also has continued funding the development of Levulan(R) PDT to treat warts and onychomycosis commonly known as nail fungus and also the development on broader labeling for the actinic keratoses indication. The group's trademarks include Levulan(R), Kerastick(R) and Blu-U(R).
